NASDAQ · Healthcare · Medical - Devices
Cytosorbents Corporation
CTSO
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. CEO Phillip Chan · Market cap $11.7M.
$3.73
-0.14 · -3.62%
52w hi $20.0052w lo $3.66
Off 52w high 69.0%
62
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
3 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Sep 04 | Phillip P. Chan | Chief Executive Officer | Buy | 200,000 | $0.35 | +$70K | 62 |
| Jun 15 | Peter J Mariani | Chief Financial Officer | Buy | 100,000 | $0.44 | +$44K | 57 |
| Jun 12 | Phillip P. Chan | Chief Executive Officer | Buy | 251,136 | $0.40 | +$100K | 65 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct